Manufactured Object – Page 31

Repare Backer Amplitude Ventures Launches $192M Biotech Fund for Development and Growth

1 year ago talkbio0Tagged Amplitude, biotech fund, Biotechnology, development aspects, Growth, Investments, Repare, Ventures

Amplitude Ventures, biotech fund, Repare Therapeutics, development, growth, investment, biotechnology

Eli Lilly Invests $5.3 Billion to Boost Production of Mounjaro and Zepbound

1 year ago1 year ago talkbio0Tagged Diabetes, Drug Industry, eli lilly, Investments, Manufacture, Mounjaro, Obesity, Weight Loss, Zepbound

** Eli Lilly, Mounjaro, Zepbound, Manufacturing, Investment, Diabetes, Obesity, Weight Loss, Pharmaceutical Industry

Bicycle Therapeutics Gears Up for Future Milestones with $555 Million Capital Infusion

1 year ago talkbio0Tagged Bicycle, Biotechnology, Capital, Catalyst, Clinical Trials, Drug Development, Infusion procedures, investors, milestones

Bicycle Therapeutics, funding, catalysts, biotechnology, drug development, clinical trials, investors, capital infusion, milestones.

Pharmaceutical Companies Prevail in 340B Case as Appeals Court Upholds Discount Restrictions

1 year ago talkbio0Tagged 340B, Appeals Court, Clinic, discounts, drugmakers, Health care facility, healthcare, Hospitals, Programs - Publication Format

340B program, drugmakers, discounts, Appeals Court, ruling, healthcare, pharmaceuticals, hospitals, clinics.

Evotec Discontinues Gene Therapy Operations, Shuts Down Austria Facility

1 year ago talkbio0Tagged Austria, Biotechnology, business operations, development aspects, Evotec, Facility (object), gene therapy, Reparative closure, research, strategic decision

Evotec, gene therapy, Austria, facility closure, strategic decision, business operations, research and development, biotechnology

AstraZeneca’s Billion-Dollar Bet: Accelerating Biopharma Innovation in China

1 year ago talkbio0Tagged AstraZeneca, Biopharma, China sales, Clinical Trials, Collaboration, development aspects, Drug Industry, Health care facility, innovation, Investments, partnerships, research

AstraZeneca, China sales, biopharma innovation, investment, research and development, healthcare market, pharmaceutical industry, clinical trials, partnerships, collaborations.

AstraZeneca Invests $1.5 Billion in Singapore for Comprehensive Antibody-Drug Conjugate Manufacturing

1 year ago talkbio0Tagged Antibody-Drug Conjugates, AstraZeneca, Biotechnology, Cancer Therapeutic Procedure, end-to-end, Investments, Manufacture, production, Singapore

AstraZeneca, Singapore, antibody-drug conjugate (ADC), manufacturing, investment, biotechnology, pharmaceuticals, end-to-end production, cancer treatment.

AstraZeneca Invests $1.5 Billion in Singapore for State-of-the-art Antibody-Drug Conjugate Manufacturing Facility

1 year ago talkbio0Tagged Antibody-Drug Conjugates, AstraZeneca, Biotechnology, Cancer Therapeutic Procedure, end-to-end, expansion, Facility (object), Generalized, innovation, Investments, Singapore

AstraZeneca, Singapore, investment, antibody-drug conjugate (ADC), manufacturing facility, end-to-end production, biotechnology, pharmaceuticals, cancer treatment, innovation, global expansion.